-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
Nmgs+Og4zMz/3udhrF+d2h/2ea7dxhwS+rpzBHm600hGhJrBvkjTP5gcvjtSrknR
u60owh4BDY6AyQCkGeTBUA==
SECURITIES AND EXCHANGE COMMISSION FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-08185 CHEMICAL FINANCIAL CORPORATION Michigan 38-2022454 333 East Main Street (989) 839-5350 Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes X No The number of shares outstanding of the Registrant's Common Stock, $1 par value, as of November 4, 2003, was 23,690,844 shares. INDEX Page FORWARD-LOOKING STATEMENTS 3 PART I. FINANCIAL INFORMATION Item 1. Financial Statements (unaudited, except Consolidated Consolidated Statements of Income for the Three and Nine Months Consolidated Statements of Financial Position as of September 30, 2003, Consolidated Statements of Cash Flows for the Nine Months Notes to Consolidated Financial Statements 7-14 Item 2. Management's Discussion and Analysis of Financial Condition and Item 3. Quantitative and Qualitative Disclosures About Market Risk 22 Item 4. Controls and Procedures 22 PART II. OTHER INFORMATION Item 6. Exhibits and Reports on Form 8-K 23 SIGNATURES 24 FORWARD-LOOKING STATEMENTS This report contains forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates and projections about the financial services industry, the economy, and the Corporation itself. Words such as "anticipates," "believes," "estimates," "judgment," "expects," "forecasts," "intends," "is likely," "plans," "predicts," "projects," "should," "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions ("risk factors") that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements. The Corporation undertakes no obligation to update, amend or clarify forward-looking statements, whether as a result of new information, future even
ts or otherwise. Risk factors include, but are not limited to, changes in interest rates and interest rate relationships; demand for products and services; the degree of competition by traditional and non-traditional competitors; changes in banking laws and regulations; changes in tax laws; changes in prices, levies and assessments; the impact of technological advances and issues; governmental and regulatory policy changes; the outcomes of pending and future litigation and contingencies; trends in customer behavior as well as their ability to repay loans; changes in the national and local economies; the local and global effects of the ongoing war on terrorism and other military actions, including actions in Iraq; and the Corporation's ability to successfully integrate acquired businesses. These are representative of the risk factors that could cause a difference between an ultimate actual outcome and a preceding forward-looking statement. PART I. FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Three Months Ended Nine Months Ended 2003 2002 2003 2002 (In thousands, except per share amounts) INTEREST INCOME Interest and fees on loans $ 36,220 $ 38,537 $ 108,789 $ 118,058 Interest on investment securities: Taxable 8,213 12,550 28,671 37,509 Tax-exempt 612 701 1,928 2,233 Total interest on Investment Securities 8,825 13,251 30,599 39,742 Interest on federal funds sold 169 542 612 1,615 Interest on deposits with unaffiliated banks 23 145 180 593 TOTAL INTEREST INCOME 45,237 52,475 140,180 160,008 INTEREST EXPENSE Interest on deposits 8,262 13,618 28,555 43,273 Interest on FHLB borrowings 2,083 2,201 6,273 6,648 Interest on other borrowings - short term 128 257 435 758 TOTAL INTEREST EXPENSE 10,473 16,076 35,263 50,679 NET INTEREST INCOME 34,764 36,399 104,917 109,329 Provision for loan losses 540 747 2,107 2,752 NET INTEREST INCOME after provision for loan losses 34,224 35,652 102,810 106,577 NONINTEREST INCOME Service charges on deposit accounts 4,181 3,966 12,334 9,602 Other charges and fees for customer services 1,623 1,864 5,372 5,418 Mortgage banking revenue 2,308 1,327 5,716 5,506 Trust services revenue 1,605 1,476 5,123 4,772 Investment securities gains (losses) 417 (99 ) 909 (184 ) Other 140 54 220 145 TOTAL NONINTEREST INCOME 10,274 8,588 29,674 25,259 OPERATING EXPENSES Salaries, wages and employee benefits 13,287 13,606 40,570 40,855 Occupancy 1,981 1,890 5,882 5,664 Equipment 2,077 2,037 6,205 6,163 Other 5,356 5,601 16,252 17,152 TOTAL OPERATING EXPENSES 22,701 23,134 68,909 69,834 INCOME BEFORE INCOME TAXES 21,797 21,106 63,575 62,002 Federal income taxes 7,328 7,088 21,422 20,739 NET INCOME $ 14,469 $ 14,018 $ 42,153 $ 41,263 NET INCOME PER SHARE (Basic) $ .61 $ .59 $ 1.78 $ 1.74 (Diluted) $ .61 $ .59 $ 1.78 $ 1.74 Cash dividends per share $ .25 $ .23 $ .75 $ .69 See accompanying notes to consolidated financial statements. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES September 30, December 31, September 30, (Unaudited) (Unaudited) ASSETS Cash and demand deposits due from banks $ 146,428 $ 148,112 $ 129,874 Federal funds sold 44,700 69,900 144,210 Interest bearing deposits with unaffiliated banks 19,905 53,135 51,725 Investment securities: Available for sale (at estimated market value) 767,562 858,744 871,795 Held to maturity (estimated market value - $242,644 at Total investment securities 1,004,473 1,127,982 1,122,054 Loans: Commercial 333,822 327,438 314,271 Real estate construction 93,282 108,589 110,212 Real estate commercial 562,937 481,084 470,547 Real estate residential 765,539 648,286 643,368 Consumer 521,310 509,789 524,312 Total loans 2,276,890 2,075,186 2,062,710 Less: Allowance for loan losses 30,414 30,672 31,000 Net loans 2,246,476 2,044,514 2,031,710 Premises and equipment 47,044 42,767 43,159 Intangible assets 39,017 40,489 41,512 Other assets 42,983 41,994 34,679 TOTAL ASSETS $ 3,591,026 $ 3,568,893 $ 3,598,923 LIABILITIES AND SHAREHOLDERS' EQUITY Deposits: Noninterest-bearing $ 500,463 $ 475,933 $ 457,330 Interest-bearing 2,369,351 2,371,339 2,402,491 Total deposits 2,869,814 2,847,272 2,859,821 FHLB borrowings 148,573 157,393 157,528 Other borrowings - short term 93,447 104,212 131,183 Interest payable and other liabilities 30,548 29,677 29,173 Total liabilities 3,142,382 3,138,554 3,177,705 Shareholders' equity: Common stock, $1 par value: Authorized - 30,000 shares Issued and outstanding - 23,685 shares, 23,684 shares, and 23,685 shares, respectively 23,685 23,684 22,558 Surplus 324,413 325,149 291,003 Retained earnings 87,106 62,721 89,822 Accumulated other comprehensive income 13,440 18,785 17,835 Total shareholders' equity 448,644 430,339 421,218 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 3,591,026 $ 3,568,893 $ 3,598,923 See accompanying notes to consolidated financial statements. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Nine Months Ended 2003 2002 (In thousands) CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 42,153 $ 41,263 Adjustments to reconcile net income to net cash provided by operating activities: Provision for loan losses 2,107 2,752 Gains on sales of loans (5,546 ) (5,011 ) Proceeds from sales of loans 364,387 333,963 Loans originated for sale (331,297 ) (310,736 ) Investment securities (gains) losses (909 ) 184 Provision for depreciation and amortization 7,411 7,280 Net amortization of investment securities 9,343 4,279 Net decrease in accrued income and other assets 2,789 1,040 Net increase in interest payable and other liabilities 871 8,296 Net Cash Provided by Operating Activities 91,309 83,310 CASH FLOWS FROM INVESTING ACTIVITIES: Securities available for sale: Proceeds from maturities, calls and principal reductions 227,883 189,174 Proceeds from sales 77,552 3,219 Purchases (247,426 ) (326,801 ) Securities held to maturity: Proceeds from maturities, calls and principal reductions 138,980 84,166 Purchases (93,335 ) (134,764 ) Net (increase) decrease in loans (231,028 ) 97,364 Purchases of premises and equipment (8,503 ) (4,354 ) Net Cash Used in Investing Activities (135,877 ) (91,996 ) CASH FLOWS FROM FINANCING ACTIVITIES: Net increase in demand deposits, NOW accounts and savings accounts 127,480 112,300 Net decrease in certificates of deposit and other time deposits (104,938 ) (42,003 ) Net increase (decrease) in other borrowings - short term (10,765 ) 12,599 Principal payments on FHLB borrowings (8,820 ) (10,365 ) Cash dividends paid (17,768 ) (16,235 ) Proceeds from shares issued 776 470 Repurchases of common stock (1,511 ) (208 ) Net Cash Provided by (Used in) Financing Activities (15,546 ) 56,558 Net Increase (Decrease) in Cash and Cash Equivalents (60,114 ) 47,872 Cash and cash equivalents at beginning of period 271,147 277,937 Cash and Cash Equivalents at End of Period $211,033 $ 325,809 Supplemental disclosure of cash flow information: Interest paid on deposits, FHLB borrowings and other borrowings - short-term $ 36,061 $ 51,485 Federal income taxes paid 18,320 21,925 See accompanying notes to consolidated financial statements. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE A: BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements of Chemical Financial Corporation (the "Corporation") have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the financial condition and results of operations of the Corporation for the periods presented. Operating results for the three and nine months ended September 30, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003. For further information, refer to the consolidated financia
l statements and footnotes thereto included in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2002. On December 9, 2002, the Corporation declared a 5% stock dividend that was paid January 24, 2003 to shareholders of record on January 6, 2003. All per share amounts and shares outstanding, where appropriate, have been adjusted for this stock dividend. Certain prior year amounts have been reclassified to place them on a basis comparable with the current period's financial statements. Earnings Per Share All earnings per share amounts have been presented to conform to the requirements of Statement of Financial Accounting Standards No. 128, "Earnings Per Share." Basic earnings per share exclude any dilutive effect of stock options. Basic earnings per share for the Corporation are computed by dividing net income by the weighted average number of common shares outstanding. Diluted earnings per share for the Corporation is computed by dividing net income by the sum of the weighted average number of common shares outstanding and the dilutive effect of outstanding employee stock options. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Earnings Per Share (continued) The following table summarizes the number of shares used in the numerator and denominator of the basic and diluted earnings per share computations: Three Months Ended Nine Months Ended 2003 2002 2003 2002 (In thousands) Numerator for both basic and diluted earnings per share, net income $ 14,469 $ 14,018 $ 42,153 $ 41,263 Denominator for basic earnings per share, average outstanding common shares 23,674 23,687 23,685 23,674 Potential dilutive shares resulting from employee stock options 61 72 52 67 Denominator for diluted earnings per share 23,735 23,759 23,737 23,741 Comprehensive Income The components of comprehensive income, net of related tax, for the three and nine months ended September 30, 2003 and 2002 are as follows (in thousands of dollars): Three Months Ended Nine Months Ended 2003 2002 2003 2002 Net income $ 14,469 $ 14,018 $ 42,153 $ 41,263 Change in unrealized net gains on investment securities available for sale (3,264 ) 5,336 (5,345 ) 6,341 Comprehensive income $ 11,205 $ 19,354 $ 36,808 $ 47,604 CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Comprehensive Income (continued) The components of accumulated other comprehensive income, net of related tax, at September 30, 2003, December 31, 2002 and September 30, 2002 are as follows (in thousands of dollars): September 30, December 31, September 30, Unrealized net gains on investment securities available for sale (net of related tax of $7,237 Accumulated other comprehensive income $13,440 $18,785 $17,835 Operating Segment Under the provisions of Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information," it is management's opinion that the Corporation operates in a single operating segment - commercial banking. The Corporation is a bank holding company that operated three commercial banks, a title insurance company and a property and casualty insurance company, each as a separate subsidiary of the Corporation, as of September 30, 2003. The Corporation's commercial bank subsidiaries operate as community banks and offer a full range of commercial banking and fiduciary products and services to the residents and business customers in their geographical market areas. The products and services offered by the commercial bank subsidiaries are generally consistent throughout the Corporation. Each of the Corporation's commercial bank subsidiaries operates within the state of Michigan. The marketing of products and services throughout the Corporation's subsidiary banks i
s generally uniform, as many of the markets served by the subsidiaries overlap. The distribution of products and services is uniform throughout the Corporation's commercial bank subsidiaries and is achieved primarily through retail branch banking offices, automated teller machines and electronically accessed banking products. The commercial bank subsidiaries are state-chartered commercial banks and operate under the same banking regulations. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Goodwill During 2002, the Corporation adopted Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets" (SFAS 142). Under SFAS 142, goodwill is no longer amortized, but is subject to annual impairment tests. The Corporation tested goodwill for impairment as of December 31, 2002. Based on these test results, the Corporation determined that there was no impairment of goodwill as of December 31, 2002. Goodwill was $27.94 million both at September 30, 2003 and 2002. Other The Corporation and its subsidiary banks are subject to certain legal actions arising in the ordinary course of business. In the opinion of management, after consultation with legal counsel, the ultimate disposition of these matters is not expected to have a material adverse effect on the consolidated income and financial position of the Corporation. NOTE B: LOANS AND NONPERFORMING ASSETS The following summarizes loans and nonperforming assets at the dates indicated (in thousands of dollars): September 30, December 31, September 30, Loans: Commercial $ 333,822 $ 327,438 $ 314,271 Real estate construction 93,282 108,589 110,212 Real estate commercial 562,937 481,084 470,547 Real estate residential 765,539 648,286 643,368 Consumer 521,310 509,789 524,312 Total Loans $2,276,890 $2,075,186 $2,062,710 Nonperforming Assets: Nonaccrual loans $ 5,268 $ 4,859 $ 8,269 Loans 90 days or more past due and still accruing interest 3,776 2,422 5,677 Total Nonperforming Loans 9,044 7,281 13,946 Repossessed assets acquired (1) 5,798 4,298 1,559 Total Nonperforming Assets $ 14,842 $ 11,579 $ 15,505 (1) Includes property acquired through foreclosure and by acceptance of a deed in lieu of foreclosure, and other property held for sale. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE C: ALLOWANCE FOR LOAN LOSSES The following summarizes the changes in the allowance for loan losses (in thousands of dollars): Nine Months Ended 2003 2002 Allowance for Loan Losses Balance as of January 1 $30,672 $30,994 Provision for loan losses 2,107 2,752 Gross loans charged off (2,881 ) (3,189 ) Gross recoveries of loans previously charged off 516 443 Net loans charged off (2,365 ) (2,746 ) Balance as of end of period $30,414 $31,000 The Corporation considers all nonaccrual commercial and commercial real estate loans to be impaired loans. Impaired loans as of September 30, 2003 and 2002 were $4.3 million and $6.6 million, respectively. The allowance for impaired loans was $200,000 and $550,000 as of September 30, 2003 and 2002, respectively. NOTE D: ACQUIRED INTANGIBLE ASSETS The following table sets forth the carrying amount, accumulated amortization and amortization expense of acquired intangible assets (in thousands): September 30, 2003 December 31, 2002 September 30, 2002 Carrying Accumulated Carrying Accumulated Carrying Accumulated Core Deposit Intangibles $8,539 $9,301 $9,898 $7,942 $10,348 $7,492 Other 129 46 155 20 163 12 Amortization expense for the: Quarter ended September 30, 2003 $ 462 Nine months ended September 30, 2003 1,385 Quarter ended September 30, 2002 496 Nine months ended September 30, 2002 1,495 Year ended December 31, 2002 1,953 CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Estimated amortization expense for the years ending December 31: 2003 $1,848 2004 $1,819 2005 $1,721 2006 $1,607 2007 $1,520 NOTE E: STOCK OPTIONS The Corporation periodically grants stock options for a fixed number of shares with an exercise price equal to the market value of the shares on the date of grant. In accordance with Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation," the Corporation accounts for stock option grants under the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" (APB 25). Under APB 25, because the exercise prices of the Corporation's stock options equal the market prices of the underlying stock at the dates of grant, no compensation expense is recognized at the date of grant. If the Corporation had elected to recognize compensation cost for options outstanding in the three- and nine-month periods ended September 30, 2003 and 2002, based on the fair value of the options granted at the grant dates, net income and earnings per share would have been reduced to the pro forma amounts indicated below (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2003 2002 2003 2002 Net income - as reported $14,469 $14,018 $42,153 $41,263 Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects (64 ) (43 ) (191 ) (128 ) Net income - pro forma $14,405 $13,975 $41,962 $41,135 Basic earnings per share - as reported $ .61 $ .59 $ 1.78 $ 1.74 Basic earnings per share - pro forma .61 .59 1.77 1.74 Diluted earnings per share - as reported .61 .59 1.78 1.74 Diluted earnings per share - pro forma .61 .59 1.77 1.73 CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE F: FINANCIAL GUARANTEES In the normal course of business, the Corporation is a party to financial instruments containing credit risk that are not required to be reflected in the consolidated statement of financial position. For the Corporation, these financial instruments are financial and performance standby letters of credit. The Corporation has risk management policies to identify, monitor and limit exposure to credit risk. To mitigate credit risk for these financial guarantees, the Corporation generally determines the need for specific covenant, guarantee and collateral requirements on a case-by-case basis, depending on the nature of the financial instrument and the customer's creditworthiness. At September 30, 2003, the Corporation had $19.5 million of outstanding financial and performance standby letters of credit. In 2002, the Financial Accounting Standards Board issued Interpretation No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others" ("FIN No. 45"), which requires additional disclosures by a guarantor about its obligations under certain guarantees that it has issued. FIN No. 45 also clarifies that a guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken in issuing the guarantee. The instruments impacted for the Corporation are financial and performance standby letters of credit. The accounting pronouncements of FIN No. 45 became effective for the Corporation on January 1, 2003, on a prospective basis. The impact of adoption was not material to the Corporation's consolidated results of operations, financial position or cash flows. NOTE G: OTHER On September 25, 2003, the Corporation announced the signing of a definitive agreement for the acquisition of Caledonia Financial Corporation ("Caledonia"). Caledonia is a bank holding company headquartered in Caledonia, Michigan, with total assets of approximately $210 million, total deposits of $181 million and total shareholders' equity of $21.3 million, all as of June 30, 2003. Caledonia is the parent company of the State Bank of Caledonia, which will continue to operate as a separate subsidiary of the Corporation until the bank is restructured in the third quarter of 2004. Caledonia provides banking services through four offices located in Kent, Kalamazoo and Barry counties in Michigan. In the transaction, shareholders of Caledonia will receive $39.00 cash for each share of Caledonia common stock in a taxable transaction. The total value of the transaction is currently estimated at approximately $55.3 million. The Corporation expects the transaction to be slightly accretive to consolidated net income
in 2004. On September 30, 2003, the Corporation consolidated CFC Data Corp., its wholly-owned data processing subsidiary, into the parent. The data processing subsidiary primarily performs data processing functions for the Corporation's commercial bank subsidiaries. NOTE H: PENDING ACCOUNTING PRONOUNCEMENTS In January 2003, Financial Accounting Standards Board ("FASB") issued Interpretation No. 46, "Consolidation of Variable Interest Entities" ("FIN 46") which provides guidance on how to identify a variable interest entity ("VIE"), and when the assets, liabilities, noncontrolling interests and results of operations of a VIE need to be included in a company's consolidated financial statements. In general, a VIE is an entity that lacks sufficient equity or its equity holders lack adequate decision making ability. If either of these characteristics is present, the entity is subject to FIN 46's variable interests consolidation model, and consolidation is based on variable interests, not on ownership of the entity's outstanding voting stock. Variable interests are defined as contractual, ownership, or other money interests in an entity that change with fluctuations in the entity's net asset value. The primary beneficiary consolidates the VIE; primary beneficiary is defined as the enterprise that absorbs a majority of expected losses or receives a majority of residual returns (if the losses or returns occur), or both. Entities not determined to be VIE's would continue to be subject to the guidance provided in ARB 51, "Consolidated Financial Statements", which generally requires consolidation based on ownership of the entity's outstanding voting stock. In October 2003, the FASB issued FASB Staff Position ("FSP") No. FIN 46-6 "Effective Date of FASB Interpretation No. 46, Consolidation of Variable Interest Entities." This FSP deferred the date the Corporation is required to adopt FIN 46 until December 31, 2003 for all interests in VIE's created before February 1, 2003. The FASB staff has announced that further guidance on FIN 46 will be issued in the fourth quarter of 2003. The adoption of FIN 46 is not expected to have a material impact on the Corporation's consolidated financial position or results of operations. ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following is management's discussion and analysis of certain significant factors that have affected the Corporation's financial condition and results of operations during the periods included in the consolidated financial statements included in this filing. SUMMARY The Corporation's net income was $14.5 million in the third quarter of 2003, up 3.2% over net income of $14.0 million in the third quarter of 2002. Earnings per share in the third quarter of 2003 were $.61, an increase of 3.4% over earnings per share of $.59 in the third quarter of 2002. The increase in net income was principally the result of higher noninterest income. This factor was partially offset by lower net interest income. Return on average assets in the third quarter of 2003 was 1.60%, compared to 1.58% for the third quarter of 2002. Return on average equity in the third quarter of 2003 was 12.9%, compared to 13.5% in the third quarter of 2002. The Corporation's net income was $42.2 million, or $1.78 per share in the first nine months of 2003, compared to net income of $41.3 million, or $1.74 per share in the first nine months of 2002. The increase in net income and earnings per share in the first nine months of 2003 was primarily due to an increase in noninterest income and a decrease in the provision for loan losses and operating expenses. These amounts were partially offset by a decrease in net interest income. Return on average assets in the nine months ended September 30, 2003 was 1.58%, compared to 1.56% for the nine months ended September 30, 2002. Return on average equity in the nine months ended September 30, 2003 was 12.8%, compared to 13.8% in the first nine months of 2002. Total assets were $3.59 billion as of September 30, 2003, up $22 million, or .6%, from total assets of $3.57 billion as of December 31, 2002, and down $8 million, or .2%, from total assets of $3.60 billion as of September 30, 2002. Total loans increased $202 million, or 9.7%, from December 31, 2002, and $214 million, or 10.4%, from September 30, 2002 to $2.28 billion as of September 30, 2003. The increase in total loans was primarily due to growth in residential and commercial real estate loans. During the first half of 2003, the Corporation held in its portfolio a portion of the fixed-rate residential real estate loan originations with maturities of fifteen to twenty years. The Corporation's general practice is to sell these types of loans in the secondary market. The growth in residential real estate loans was undertaken to achieve the Corporation's desired mix of residential loans to total loans and to partially offset the negative impact of a lower net interest margin. The outstanding residential real estate loan portfolio balance declined in 2002 as customers took advantage of the historically low long-term fixed interest rate environment by refinancing their existing residential mortgage loans. The increase in commercial real
estate loans is due to increased emphasis by the Corporation on developing commercial relationships. Shareholders' equity increased $27.4 million, or 6.5%, from September 30, 2002 to $448.6 million as of September 30, 2003, or $18.94 per share, representing 12.5% of total assets. The increase was primarily attributable to retained net income. RESULTS OF OPERATIONS Net Interest Income The Corporation's net interest income in the third quarter of 2003 was $34.8 million, a $1.6 million, or 4.5%, decrease from the $36.4 million recorded in the third quarter of 2002. The decrease was primarily due to a lower net interest margin. Net interest margin decreased to 4.12% in the third quarter of 2003 from 4.40% in the third quarter of 2002. The decrease in net interest income was partially offset by an increase in average interest-earning assets, which increased $62 million, or 1.9%, in the third quarter of 2003, compared to the third quarter of 2002. Net interest income was $104.9 million in the nine months ended September 30, 2003, a $4.4 million, or 4.0%, decrease from the $109.3 million recorded in the first nine months in 2002. The decrease was primarily due to a lower net interest margin. Net interest margin decreased to 4.20% in the first nine months of 2003 from 4.47% in the first nine months of 2002. The decrease in net interest income was partially offset by an increase in average interest-earning assets, which increased $71 million, or 2.1%, in the first nine months of 2003, compared to the first nine months of 2002. Provision for Loan Losses The provision for loan losses ("provision") is the amount added to the allowance for loan losses ("allowance") to absorb loan losses in the loan portfolio. The allowance provides for probable losses that have been identified with specific customer relationships and for probable losses believed to be inherent in the remainder of the loan portfolio but that have not been specifically identified. The allowance is comprised of specific allowances (assessed for loans that have known credit weaknesses), general allowances based on an assigned risk rating and an unallocated allowance for imprecision in the subjective nature of the specific and general allowance methodology. Management continuously evaluates the allowance to ensure the level is adequate to absorb losses inherent in the loan portfolio. This evaluation is based on a continuous review of the loan portfolio, both individually and by category, and includes consideration of changes in the mix and volume of the loan portfolio, actual loan loss experienc
e, the financial condition of the borrowers, industry and geographical exposures within the portfolio, economic conditions and employment levels of the Corporation's local markets, and other factors affecting business sectors. A formal evaluation of the allowance is prepared quarterly to assess the risk in the loan portfolio and to determine the adequacy of the allowance. The Corporation's loan review personnel, who are independent of the loan origination function, review this evaluation. The provision for loan losses was $.54 million in the third quarter of 2003 and $2.1 million in the first nine months of 2003, compared to $.75 million in the third quarter and $2.8 million in the first nine months of 2002. Net loan losses were $.61 million in the third quarter and $2.36 million in the first nine months of 2003, compared to $.76 million in the third quarter and $2.75 million in the first nine months of 2002. Noninterest Income Noninterest income increased $1.7 million, or 19.6%, in the third quarter of 2003, compared to the third quarter of 2002. The increase was primarily due to higher mortgage banking revenue of $1.0 million and higher gains on investment securities of $516,000. Mortgage banking volume remained strong during the third quarter of 2003. The third quarter of 2003 was negatively impacted by higher
Washington, D.C. 20549
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2003, OR
FOR THE TRANSITION PERIOD FROM ____________ TO ____________
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction
of Incorporation or Organization)
(I.R.S. Employer
Identification No.)
Midland, Michigan
(Address of Principal Executive Offices)
48640
(Zip Code)
(Registrant's Telephone Number, Including Area Code)
CHEMICAL FINANCIAL CORPORATION
FORM 10-Q
Statement of Financial Position as of December 31, 2002)
Ended September 30, 2003 and September 30, 2002
4
December 31, 2002 and September 30, 2002
5
Ended September 30, 2003 and September 30, 2002
6
Results of Operations
15-21
Consolidated Statements of Income (Unaudited)
September 30
September 30
Consolidated Statements of Financial Position (In thousands)
2003
2002
2002
9/30/03, $277,231 at 12/31/02, $258,263 at 9/30/02)
236,911
269,238
250,259
Consolidated Statements of Cash Flows (Unaudited)
September 30
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2003
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2003
September 30
September 30
September 30
September 30
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2003
2003
2002
2002
at 9/30/03, $10,115 at 12/31/02, $9,603 at
9/30/02)
$13,440
$18,785
$17,835
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2003
2003
2002
2002
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2003
September 30
Amount
Amortization
Amount
Amortization
Amount
Amortization
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2003
September 30
September 30
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2003
amortization of servicing rights as well as a $513,000 impairment provision recorded to reflect the decline in the estimated value of mortgage servicing rights compared to the recorded book value. The decline in the estimated fair value of mortgage servicing rights was due to the continued decline in market interest rates for residential mortgages and the corresponding increase in prepayments of loans serviced for others.
Noninterest income increased $4.4 million, or 17.5%, in the first nine months of 2003, compared to the first nine months of 2002. The increase was primarily due to higher service charges on deposit accounts of $2.7 million and higher gains on investment securities of $1.1 million. The increase in service charges was attributable to a higher level of customer activity in areas where fees and service charges are applicable.
Operating Expenses
Total operating expenses decreased $433,000, or 1.9%, in the third quarter of 2003, compared to the third quarter of 2002. The decrease in operating expenses was due to a decrease in employee benefit expense due to health insurance rebates related to prior years, Michigan Single Business taxes and other miscellaneous expenses.
Total operating expenses decreased $925,000, or 1.3%, in the first nine months of 2003, compared to the first nine months of 2002. The decrease in operating expenses was due to the same reasons explained in the above paragraph.
Income Tax Expense
The Corporation's effective federal income tax rate was 33.6% in the third quarter and 33.7% in the first nine months of 2003, compared to 33.6% in the third quarter and 33.4% in the first nine months of 2002. The difference between the federal statutory income tax rate and the Corporation's effective federal income tax rate primarily is a function of the proportion of the Corporation's interest income exempt from federal taxation, nondeductible interest expense and other nondeductible expenses.
BALANCE SHEET CHANGES
Asset and Deposit Changes
Total assets increased $22.1 million, or .6%, from December 31, 2002 and decreased $7.9 million, or .2%, from September 30, 2002 to $3.59 billion as of September 30, 2003. Total deposits increased $22.5 million, or .8%, from December 31, 2002, and increased $10.0 million, or .3%, from September 30, 2002 to $2.87 billion as of September 30, 2003. The growth in total assets was attributable to deposit and retained net income growth.
Loans
The Corporation's philosophy is such that it will not compromise on loan quality and generally does not make loans outside its banking markets to increase its loan portfolio. In addition, the Corporation generally does not participate in syndicated loans, which is a method utilized by many financial institutions to increase the size of their loan portfolios. The Corporation's loan portfolio
Total loans as of September 30, 2003 were $2.28 billion, compared to $2.08 billion as of December 31, 2002 and $2.06 billion as of September 30, 2002.
Residential real estate loans increased $117.3 million, or 18.1%, from December 31, 2002 and $122.2 million, or 19.0%, from September 30, 2002 to $765.5 million as of September 30, 2003. Residential real estate loans represented 33.6%, 31.2% and 31.2% of the Corporation's loan portfolio as of September 30, 2003, December 31, 2002 and September 30, 2002, respectively. The Corporation's residential real estate loans primarily consist of one- to four-family residential loans with original terms of fifteen years or less. The loan-to-value ratio at time of origination is generally 80% or less. Loans with more than an 80% loan-to-value ratio generally require private mortgage insurance.
Real estate construction loans decreased $15.3 million, or 14.1%, from December 31, 2002 and $16.9 million, or 15.4%, from September 30, 2002 to $93.3 million as of September 30, 2003. Real estate construction loans represented 4.1%, 5.2% and 5.3% of the Corporation's loan portfolio as of September 30, 2003, December 31, 2002 and September 30, 2002, respectively. Construction lending is generally considered to involve a higher degree of risk than one- to four-family residential lending because of the uncertainties of construction, including the possibility of costs exceeding the initial estimates and the need to obtain a tenant or purchaser of the property if it will not be owner-occupied. The Corporation generally attempts to mitigate the risks associated with construction lending by, among other things, lending primarily in its market area, using conservative underwriting guidelines, and closely monitoring the construction process.
Commercial loans increased $6.4 million, or 1.9%, from December 31, 2002, and $19.6 million, or 6.2%, from September 30, 2002 to $333.8 million as of September 30, 2003. Commercial loans represented 14.7%, 15.8% and 15.3% of the Corporation's loan portfolio as of September 30, 2003, December 31, 2002 and September 30, 2002, respectively.
Commercial real estate loans increased $81.9 million, or 17.0%, from December 31, 2002 and $92.4 million, or 19.6%, from September 30, 2002 to $562.9 million as of September 30, 2003. Commercial real estate loans represented 24.7%, 23.2% and 22.8% of the Corporation's loan portfolio as of September 30, 2003, December 31, 2002 and September 30, 2002, respectively.
Commercial lending and commercial real estate lending are generally considered to involve a higher degree of risk than one- to four-family residential lending. Such lending typically involves large loan balances concentrated in a single borrower for rental or business properties or for the operation of a business. In addition, the payment experience on loans secured by income-producing properties is typically dependent on the success of the operation of the related project and thus is typically affected by adverse conditions in the real estate market and in the economy. The Corporation generally attempts to mitigate the risks associated with commercial lending by, among other things, lending primarily in its market area and using conservative loan-to-value ratios in the underwriting process.
Consumer loans increased $11.5 million, or 2.3%, from December 31, 2002, and decreased $3.0 million, or .6%, from September 30, 2002 to $521.3 million as of September 30, 2003. Consumer loans represented 22.9%, 24.6% and 25.4% of total loans as of September 30, 2003, December 31, 2002 and September 30, 2002, respectively.
Consumer loans generally have shorter terms than mortgage loans but generally involve more credit risk than one- to four-family residential lending because of the type and nature of the collateral. However, consumer lending generally involves less credit risk than commercial lending. Consumer lending collections are dependent on the borrower's continuing financial stability, and thus are more likely to be negatively affected by adverse personal situations.
The Corporation's total loan to deposit ratio as of September 30, 2003, December 31, 2002 and September 30, 2002 was 79.3%, 72.9% and 72.1%, respectively.
Nonperforming loans consist of loans which are past due for principal or interest payments by 90 days or more and are still accruing interest, loans for which the accrual of interest has been discontinued, and other loans which have been restructured to less than market terms due to a serious weakening of the borrower's financial condition. Nonperforming loans were $9.0 million as of September 30, 2003, $7.3 million as of December 31, 2002 and $13.9 million as of September 30, 2002, and represented .40%, .35% and .68% of total loans, respectively. The increase in nonperforming loans since December 31, 2002 was due to an increase of $1.4 million in loans past due 90 days or more and still accruing interest. Real estate residential loans represented approximately one-half of the increase.
A loan is considered impaired when management determines it is probable that all of the principal and interest due under the contractual terms of the loan will not be collected. In most instances, the impairment is measured based on the fair market value of the underlying collateral. Impairment may also be measured based on the present value of expected future cash flows discounted at the loan's effective interest rate. A portion of the allowance for loan losses may be allocated to impaired loans. The Corporation has taken the position that all nonaccrual commercial and commercial real estate loans are considered to be impaired loans.
Impaired loans totaled $4.3 million as of September 30, 2003, $2.3 million as of December 31, 2002 and $6.6 million as of September 30, 2002. After analyzing the various components of the customer relationships and evaluating the underlying collateral of impaired loans, the allowance for loan losses allocated to impaired loans was as follows: $.2 million as of September 30, 2003, $.8 million as of December 31, 2002 and $.6 million as of September 30, 2002. The process of measuring impaired loans and the allocation of the allowance for loan losses requires judgment and estimation; therefore the eventual outcome may differ from the estimates used on these loans.
The allowance for loan losses at September 30, 2003 was $30.4 million and represented 1.34% of total loans, compared to $30.7 million, or 1.48% of total loans at December 31, 2002 and $31.0 million, or 1.50% of total loans at September 30, 2002.
Liquidity
The maintenance of an adequate level of liquidity is necessary to ensure that sufficient funds are available to meet customers' loan demands and deposit withdrawals and to capitalize on opportunities for business expansion. The banking subsidiaries' primary liquidity sources consist of investment securities, those maturing within one year and those classified as available for sale, loan payments and federal funds sold.
The Corporation has various commitments that may impact liquidity. The following table summarizes the Corporation's commitments and expected expiration dates by period at September 30, 2003. Since many of these commitments historically have expired without being drawn upon, the total amount of these commitments does not necessarily represent future cash requirements of the Corporation.
Commitments (in thousands)
|
Expected Expiration Dates by Period |
||||||||
|
|
|
|
|
|
|
|
|
More |
Unused commitments to extend credit |
$338,056 |
|
$251,268 |
|
$23,177 |
|
$47,381 |
|
$16,230 |
Undisbursed loans |
145,123 |
|
145,123 |
|
- |
|
- |
|
- |
Standby letters of credit and financial guarantees |
19,531 |
|
8,485 |
|
4,701 |
|
5,362 |
|
983 |
Total commitments |
$502,710 |
|
$404,876 |
|
$27,878 |
|
$52,743 |
|
$17,213 |
Capital Resources
As of September 30, 2003, shareholders' equity was $448.6 million, compared to $430.3 million as of December 31, 2002 and $421.2 million as of September 30, 2002, resulting in an increase of $18.3 million, or 4.3%, from December 31, 2002 and $27.4 million, or 6.5%, from September 30, 2002. Shareholders' equity as a percentage of total assets was 12.5% as of September 30, 2003, 12.1% as of December 31, 2002 and 11.7% as of September 30, 2002.
A statement of changes in shareholders' equity covering the nine-month periods ended September 30, 2003 and September 30, 2002 follows (in thousands):
|
Nine Months Ended |
|
||
|
2003 |
|
2002 |
|
Total shareholders' equity as of January 1 |
$430,339 |
|
$389,456 |
|
Comprehensive income: |
|
|
|
|
Net income |
42,153 |
|
41,263 |
|
Change in unrealized net gains on securities |
|
|
|
|
available for sale, net of tax |
(5,345 |
) |
6,341 |
|
Total comprehensive income |
36,808 |
|
47,604 |
|
Cash dividends paid |
(17,768 |
) |
(16,235 |
) |
Shares issued from stock option and other plans |
776 |
|
601 |
|
Repurchases of shares |
(1,511 |
) |
(208 |
) |
Total shareholders' equity as of end of period |
$448,644 |
|
$421,218 |
|
The following table represents the Corporation's regulatory capital ratios as of September 30, 2003:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemical Financial Corporation-actual ratio |
11.2 |
% |
17.6 |
% |
18.8 |
% |
|
|
|
|
|
|
|
Regulatory minimum ratio |
3.0 |
|
4.0 |
|
8.0 |
|
|
|
|
|
|
|
|
Ratio considered "well capitalized" by |
|
|
|
|
|
|
The Corporation's Tier 1 and Total capital ratios under the risk-based capital measure at September 30, 2003 exceed the regulatory agencies ratios to be considered "well capitalized" partially due to the Corporation holding $306 million in investment securities and other assets which are assigned a 0% risk rating; $797 million in assets, primarily investment securities, which are assigned a 20% risk rating; and $876 million in residential real estate mortgages and other assets which are assigned a 50% risk rating. These three risk ratings (0%, 20% and 50%) represented 53.3% of the Corporation's total risk-based assets (including off-balance sheet items) as of September 30, 2003.
During the nine months ended September 30, 2003, the Company repurchased 52,000 shares of its common stock at an average price of $29.06 per share under the 2001 Stock Repurchase Program. The 2001 Stock Repurchase Program allows for the repurchase of up to 441,000 shares, of which 361,779 shares were available for future repurchase at September 30, 2003.
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
The information concerning quantitative and qualitative disclosures about market risk contained in the discussion regarding interest rate risk and sensitivity under the caption "Liquidity Risk" and "Interest Rate Risk" on pages 16 through 20 of the Corporation's Annual Report to Shareholders for the year ended December 31, 2002 is here incorporated by reference. Such Annual Report was previously filed as Exhibit 13 to the Corporation's Annual Report on Form 10-K for the year ended December 31, 2002.
The Corporation does not believe that there has been a material change in the nature or categories of the Corporation's primary market risk exposures, or the particular markets that present the primary risk of loss to the Corporation. As of the date of this report, the Corporation does not know of or expect there to be any material change in the general nature of its primary market risk exposure in the near term. The methods by which the Corporation manages its primary market risk exposures, as described in the sections of its Annual Report to Shareholders incorporated by reference in response to this item, have not changed materially during the current year. As of the date of this report, the Corporation does not expect to make material changes in those methods in the near term. The Corporation may change those methods in the future to adapt to changes in circumstances or to implement new techniques.
The Corporation's market risk exposure is mainly comprised of its vulnerability to interest rate risk. Prevailing interest rates and interest rate relationships are primarily determined by market factors that are beyond the Corporation's control. All information provided in response to this item consists of forward-looking statements. Reference is made to the section captioned "Forward-Looking Statements" in this report for a discussion of the limitations on the Corporation's responsibility for such statements. In this discussion, "near term" means a period of one year following the date of the most recent consolidated statement of financial position contained in this report.
ITEM 4. |
CONTROLS AND PROCEDURES |
An evaluation was performed under the supervision and with the participation of the Corporation's management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Corporation's disclosure controls and procedures. Based on and as of the time of such evaluation, the Corporation's management, including the Chief Executive Officer and Chief Financial Officer, concluded that the Corporation's disclosure controls and procedures were effective as of the end of the period covered by this report. There was no change in the Corporation's internal control over financial reporting that occurred during the three months ended September 30, 2003 that has materially affected, or that is reasonably likely to materially affect, the Corporation's internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 6. |
EXHIBITS AND REPORTS ON FORM 8-K |
(a) |
Exhibits. The following exhibits are filed as part of this report on Form 10-Q: |
|||
|
|
|
|
|
|
Exhibit |
|
|
|
|
|
|
|
|
|
3.1 |
|
Restated Articles of Incorporation. Previously filed as Exhibit 4.1 to the Corporation's Registration Statement on Form S-8 filed with the Commission on March 2, 2001. Here incorporated by reference. |
|
|
|
|
|
|
|
3.2 |
|
Bylaws. Previously filed as Exhibit 3.2 to the Corporation's Annual Report on Form 10-K for the year ended December 31, 2001. Here incorporated by reference. |
|
|
|
|
|
|
|
31.1 |
|
Certification. Certification of President and Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
31.2 |
|
Certification. Certification of Executive Vice President, Chief Financial Officer and Treasurer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
32.1 |
|
Certification pursuant to 18 U.S.C. § 1350. |
|
|
|
|
|
|
(b) |
Reports on Form 8-K. During the three-month period ended September 30, 2003, the following reports were filed on Form 8-K: |
|
Date |
Item Reported |
Financial Statements |
|
|
|
|
|
|
|
July 22, 2003 |
7(c), 9 |
None |
|
|
September 25, 2003 |
7(c), 9 |
None |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
CHEMICAL FINANCIAL CORPORATION |
|
|
Date: November 10, 2003 |
By: /s/ David B. Ramaker |
|
David B. Ramaker |
|
|
|
|
Date: November 10, 2003 |
By: /s/ Lori A. Gwizdala |
|
Lori A. Gwizdala |
EXHIBIT INDEX
Exhibit |
|
|
|
|
|
3.1 |
|
Restated Articles of Incorporation. Previously filed as Exhibit 4.1 to the Corporation's Registration Statement on Form S-8 filed with the Commission on March 2, 2001. Here incorporated by reference. |
|
|
|
3.2 |
|
Bylaws. Previously filed as Exhibit 3.2 to the Corporation's Annual Report on Form 10-K for the year ended December 31, 2001. Here incorporated by reference. |
|
|
|
31.1 |
|
Certification. Certification of President and Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2 |
|
Certification. Certification of Executive Vice President, Chief Financial Officer and Treasurer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1 |
|
Certification pursuant to 18 U.S.C. § 1350. |
EXHIBIT 31.1
CERTIFICATIONS
I, David B. Ramaker, certify that:
1. |
I have reviewed this quarterly report on Form 10-Q of Chemical Financial Corporation; |
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
4. |
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
b) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
c) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. |
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: November 10, 2003
/s/ David B. Ramaker |
|
David B. Ramaker |
|
EXHIBIT 31.2
CERTIFICATIONS
I, Lori A. Gwizdala, certify that:
1. |
I have reviewed this quarterly report on Form 10-Q of Chemical Financial Corporation; |
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
4. |
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
b) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
c) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. |
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: November 10, 2003
/s/ Lori A. Gwizdala |
|
Lori A. Gwizdala |
|
EXHIBIT 32.1
CERTIFICATION
Pursuant to 18 U.S.C. § 1350, each of the undersigned hereby certifies in his or her capacity as an officer of Chemical Financial Corporation (the "Company") that the Quarterly Report of the Company on Form 10-Q for the quarter ended September 30, 2003 fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition of the Company at the end of such period and the results of operations of the Company for such period.
Dated: November 10, 2003 |
/s/ David B. Ramaker |
|
David B. Ramaker |
|
|
|
|
|
|
Dated: November 10, 2003 |
/s/ Lori A. Gwizdala |
|
Lori A. Gwizdala |